ETFs positioned on Tactile Systems Technology, Inc.

Logo Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
Employees
1,037
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
26.45USD
Average target price
29.75USD
Spread / Average Target
+12.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. TCMD Stock
  4. ETFs Tactile Systems Technology, Inc.